Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

NCT01351350 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancies
Hematologic Malignancies

Interventions

DRUG: MLN0128
DRUG: paclitaxel
DRUG: trastuzumab

Sponsor

Millennium Pharmaceuticals, Inc.